Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinomaMan Liu, Hongchuan Jin, Jie Chen et al.|Gut|2019Cited by 182
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liverWenshu Tang, Alfred S.L. Cheng, Jingying Zhou et al.|Cellular and Molecular Immunology|2022Cited by 112
Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogrammingLei Xiong, Ka‐Fai To, Feng Wu et al.|Nature Communications|2019Cited by 105
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Alfred S.L. Cheng, Weiqin Yang et al.|Nature Communications|2018Cited by 94
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesisYing‐Ying Lee, Alfred S.L. Cheng, Myth T.S. Mok et al.|Nucleic Acids Research|2018Cited by 67